References
- . Kessler RC, Adler LA, Barkley R,. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723
- . Adler LA, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin N Am. 2004;27:187–201
- . Adler LA, Chua HC. Management of ADHD in adults. J Clin Psychiatry. 2002;63( suppl 12):29–35
- . Barkley RA. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York, NY: Guilford Press; 1998
- . World Health Organization. Adherence to long-term therapies: evidence for action. Geneva, Switzerland; 2003:18
- . Cantrell CR, Eaddy MT, Shah MB, Regan TS, Sokol MC. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care. 2006;44(4):300–303
- . Sanchez RJ, Crismon ML, Barner JC, Bettinger T, Wilson JP. Assessment of adherence measures with different stimulants among children and adolescents. Pharmacotherapy. 2005;25(7):909–917
- . Safren SA, Duran P, Yovel I, Perlman CA, Sprich S. Medication adherence in psychopharmacologically treated adults with ADHD. J Atten Disord. 2007;10(3):257–260
- . Ibrahim el SR. Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder. Hum Psychopharmocol. 2002;17(5):225–231
- . Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry. 2004;43(5):559–567
- . Marcus SC, Wan GJ, Kemner JE, Olfson M. Continuity of methylphenidate treatment for attention-deficit/ hyperactivity disorder. Arch Pediatr Adolesc Med. 2005;159(6):572–578
- . Faraone SV, Biederman J, Zimmerman B. An analysis of patient adherence to treatment during a 1-year, open-label study of OROS-methylphenidate in children with ADHD. J Atten Disord. 2007;11(2):64–73
- . Winterstein AG, Gerhard T, Shuster J,. Utilization of pharmacologic treatment in youth with attention deficit/hyperactivity disorder in Medicaid database. Ann Pharmacother. 2008;42(1):24–31
- . Pappadopulos E, Jensen PS, Chait AR,. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry. 2009;48(5):501–510
- . Olfson M, Marcus S, Wan G. Stimulant dosing for children with ADHD: a medical claims analysis. J Am Acad Child Psychiatry. 2009;48(1):51–59
- . Chou WJ, Chou MC, Tzang RF,. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes. Psychiatry Clin Neurosci. 2009;63(2):167–175
- . Perwien AR, Hall J, Swensen A, Swindle R. Stimulant treatment patterns and compliance in children and adults with newly treated attention-defict/hyperactivity disorder. J Manag Care Pharm. 2004;10(2):122–129
- . Olfson M, Marcus SC, Zhang HF, Wan GJ. Continuity of methylphenidate treatment of adults with attention-deficit/hyperactivity disorder. J Manag Care Pharm. 2007;13(7):570–577
- . Nierenberg AA, Ostacher MJ, Borrelli DJ,. The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry. J Clin Psychiatry. 2006;67( suppl 11):3–7